Medical Devices

With 17 abstracts at AAD 2026, LEO Pharma showcases real-world data to tackle treatment gaps in diverse populations and chronic skin diseases.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

A brain aneurysm device successful in Europe has treated its first U.S. patient in a pivotal trial, promising to expand treatment options for thousands.

A 30-year-old breakthrough could revolutionize physics and cancer detection. Its inventor now demands a public test to prove it, alleging a cover-up.

With six top honors at a key summit, Fortis Healthcare highlights India's rapid growth as a trusted, affordable destination for advanced medical treatment.

An influential guidelines update expands options for a tough-to-treat bladder cancer, giving patients access to a novel gene therapy beyond its FDA label.

Two surgery centers operated by Constitution Surgery Alliance have been named among the nation's best, highlighting a trend of excellence in outpatient care.

Curia announces major upgrades to its UK sterile manufacturing and US biologics platforms, a strategic move to accelerate drug development timelines.

Endovascular Engineering's Hēlo system data, set for two major meetings, promises to validate blood return safety and reshape real-world PE care.

A new oral drug is being tested with existing therapies, offering a two-pronged attack on the glycogen buildup that defines this debilitating rare disease.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

With two new powerhouse executives, Phoenix Children's is poised to execute a bold new vision for pediatric care, targeting workforce, growth, and community impact.

ImmunoBrain's novel immunotherapy for Alzheimer's avoids key safety issues of other drugs and shows positive biomarker data in a Phase 1b trial.

With Saumay Kumar as new CEO and Timothy Kelley as CSO, TeleRay is betting a dual-leadership model will accelerate growth and define the future of virtual care.

Ractigen's RAG-01 advances with NMPA approval, using RNA activation to fight bladder cancer by targeting a previously 'undruggable' gene.

Quebec’s new budget maintains support for its vital life sciences sector, but industry leaders warn new tax rules could hinder innovation for small firms.

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

After his own diagnosis, golfer Brian Gay advocates for GentleCure, a non-surgical option with a 99% cure rate that kept him on the course.

A new partnership signals a major shift in the aesthetics market, blending private equity scale with a new focus on university-backed provider education.